Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)concerning whether a series of statements by Dicerna Pharmaceuticals Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On June 10, 2015, Seeking Alpha website published a report which stated that "Alnylam Pharmaceuticals ALNY, +0.95% files a lawsuit in Massachusetts against Dicerna Pharmaceuticals accusing it of misappropriating trade secrets Alnylam acquired via its buyout of Sirna Therapeutics from Merck in January 2014.
The suit accuses Dicerna of obtaining its trade secrets by hiring six scientists from Merck who were involved in RNAi work, despite each of them signing a confidentiality agreement. It alleges that Dicerna's subsequent product candidates and delivery technologies are 'strikingly similar' to Sirna's/Merck's. It also alleges that certain scientists hired by Dicerna were seen taking material out of the Merck facility prior to their departure."
Following the publishing of this report, shares of Dicerna declined $0.88 per share, to $15.22, or more than 5.47%, in after-hours trading on June 10, 2015.
Based in Cambridge, MA and founded in 2006, Dicerna Pharmaceuticals Inc is a biopharmaceutical company whose main focus is on the discovery and development of treatments for liver diseases and cancers based on a proprietary technology called RNA interference.
If you purchased shares Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) on or before June 10, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
